Similar companies
| Company | Est. Net Value | |
|---|---|---|
 |
PfizerPFE |
-$130,000 |
 |
AstrazenecaAZN |
$32,000 |
 |
Johnson & JohnsonJNJ |
-$400,000 |
 |
ModernaMRNA |
$16,000 |
 |
AbbVieABBV |
$72,000 |
Are Members of Congress Buying or Selling Bristol-Myers Squibb?
No members of Congress have reported trading Bristol-Myers Squibb (BMY) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the BMY AI Score. For corporate insider activity, see BMY insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
Which Congress Members Are Trading Bristol-Myers Squibb?
| Member of Congress | Activity | Trades | Last Trade |
|---|---|---|---|
| Julie Johnson | Sold $32,000 | 5 | Dec 18, 2025 |
| Jefferson Shreve | Sold $33,000 | 1 | May 12, 2025 |
| Gilbert Cisneros | Bought $16,000 | 3 | Dec 19, 2025 |
| Julia Letlow | Mixed $16,000 | 2 | Apr 28, 2025 |
| Virginia Foxx | Mixed $16,000 | 2 | Jun 24, 2025 |
| Valerie Hoyle | Bought $8,000 | 1 | Oct 29, 2024 |
BMY Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Gilbert Cisneros | Dec 19, 2025 | Buy | $1K – $15K |
| Julie Johnson | Dec 18, 2025 | Sell | $1K – $15K |
| Julie Johnson | Nov 13, 2025 | Sell | $1K – $15K |
| Gilbert Cisneros | Nov 12, 2025 | Buy | $1K – $15K |
| Gilbert Cisneros | Oct 9, 2025 | Sell | $1K – $15K |
| Julie Johnson | Aug 14, 2025 | Sell | $1K – $15K |
| Virginia Foxx | Jun 24, 2025 | Sell | $1K – $15K |
| Jefferson Shreve | May 12, 2025 | Sell | $15K – $50K |
| Julia Letlow | Apr 28, 2025 | Sell | $1K – $15K |
| Tommy Tuberville | Apr 15, 2025 | Sell | $1K – $15K |
| Julie Johnson | Apr 1, 2025 | Sell | $1K – $15K |
| Greg Landsman | Mar 27, 2025 | Sell | $1K – $15K |
| Julie Johnson | Jan 15, 2025 | Buy | $1K – $15K |
| Virginia Foxx | Dec 6, 2024 | Buy | $1K – $15K |
| Valerie Hoyle | Oct 29, 2024 | Buy | $1K – $15K |
| Julia Letlow | Oct 23, 2024 | Buy | $1K – $15K |
Frequently Asked Questions: Bristol-Myers Squibb Congress Trading
No members of Congress have reported buying or selling BMY stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Gilbert Cisneros bought Bristol-Myers Squibb (BMY) stock most recently, on December 19, 2025.
The estimated net value of congressional trades in Bristol-Myers Squibb over the past 2 years is negative, at -$57,000, meaning members of Congress have on balance sold more than they have bought.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
